New Frontiers in Therapy
Andy discusses groundbreaking therapies that are showing promise in reversing liver fibrosis and addressing obesity, a condition affecting millions globally. He highlights the potential of extended-release gut hormones that can lead to significant weight loss, rivaling bariatric surgery outcomes. However, he also addresses the critical issue of drug pricing, emphasizing recent legislative changes aimed at reducing out-of-pocket costs for patients, particularly seniors.In this clip
From this podcast
Capital Allocators – Inside the Institutional Investment Industry
[REPLAY] Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274)
Related Questions